Peak Pharma - Is it time to rethink our pharmaceutical innovation system?
- Date: Thu, Jan 15, 2026
Share this article
Professor Susi Geiger to discuss the spiralling price of new drug therapies in 2026 Laurence Crowley Lecture.
By Barry McCall, The Irish Times
Professor Susi Geiger, speaker of the Laurence Crowley Lecture Series 2026. Photo: Coalesce
The spiralling price of new drug therapies is placing health systems under severe pressure. While advanced new drugs undoubtedly have positive consequences for patients, there is a risk that their benefits will be confined to the fortunate well off few if the current pharmaceutical innovation and patent system is not rethought. This is the core theme of the UCD Michael Smurfit Graduate Business School Laurence Crowley Lecture 2026 to be delivered by Prof Susi Geiger on Monday, 19 January 2026.
A full professor of markets, organisations and society at UCD, Prof Geiger is a leading international expert on pharmaceutical and digital markets, a member of the World Health Organisation technical advisory group on pharmaceutical pricing policies and an access to medicines activist.
In her lecture, Prof Geiger will present key insights from her just-published book: Peak Pharma: Toward a New Political Economy of Health (Oxford University Press).
Read the full article in The Irish Times.
The 2026 UCD Smurfit School Laurence Crowley Lecture Series will take place at 6:30pm on Monday, 19 January 2026. This event is free and open to the public. Registrations for the event is now open.
Discover our Rankings and Accreditations
